Overview

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Status:
Withdrawn

Trial end date:
2018-08-01

Target enrollment:

Participant gender:

Summary

The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).

Phase:

Phase 4

Details

Lead Sponsor:

University of Florida

Treatments:

Finasteride
Minoxidil
Spironolactone